| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |